Junshi Biosciences reports stable share capital in August monthly return

Shanghai Junshi Biosciences Co., Ltd. submitted its monthly return for the period ended August 31, 2025, indicating stable authorized/registered and issued share capital. The company's total authorized/registered share capital stands at RMB 1,026,689,871.

For H-shares, the number of authorized/registered shares remained at 260,295,700, with a par value of RMB 1 per share. The number of issued H-shares also held steady at 260,295,700. Similarly, for A-shares listed on the STAR Market, the authorized/registered shares were unchanged at 766,394,171, with a par value of RMB 1 per share. The number of issued A-shares remained at 765,578,300, alongside 815,871 treasury shares, resulting in a total of 766,394,171 issued A-shares.

No new shares were issued, and no changes occurred in treasury shares for either class during August 2025. The company confirmed that all necessary legal and regulatory requirements have been met, and all issued securities are identical.